| Product NDC: | 0456-4130 |
| Proprietary Name: | Celexa |
| Non Proprietary Name: | citalopram hydrobromide |
| Active Ingredient(s): | 10 mg/5mL & nbsp; citalopram hydrobromide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SUSPENSION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0456-4130 |
| Labeler Name: | Forest Laboratories, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA021046 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19980717 |
| Package NDC: | 0456-4130-08 |
| Package Description: | 240 mL in 1 BOTTLE (0456-4130-08) |
| NDC Code | 0456-4130-08 |
| Proprietary Name | Celexa |
| Package Description | 240 mL in 1 BOTTLE (0456-4130-08) |
| Product NDC | 0456-4130 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | citalopram hydrobromide |
| Dosage Form Name | SUSPENSION |
| Route Name | ORAL |
| Start Marketing Date | 19980717 |
| Marketing Category Name | NDA |
| Labeler Name | Forest Laboratories, Inc. |
| Substance Name | CITALOPRAM HYDROBROMIDE |
| Strength Number | 10 |
| Strength Unit | mg/5mL |
| Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |